CytoDyn Inc. Stock Issued During Period, Shares, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- CytoDyn Inc. stock issued during period, shares, new issues for the quarter ending 2026-05-31 was 0.00 shares.
- CytoDyn Inc. stock issued during period, shares, new issues for the quarter ending 2023-02-28 was 500.00K shares.
- CytoDyn Inc. stock issued during period, shares, new issues for the quarter ending 2022-08-31 was 4.60M shares.
- CytoDyn Inc. stock issued during period, shares, new issues for fiscal 2026 was 3.20M shares.
- CytoDyn Inc. stock issued during period, shares, new issues for fiscal 2022 was 7.90M shares.
- CytoDyn Inc. stock issued during period, shares, new issues for fiscal 2009 was 3.02M shares.
| Period end | Stock Issued During Period, Shares, New Issues 3 month | Stock Issued During Period, Shares, New Issues 12 month |
|---|---|---|
| 2026-05-31 | 0.00 shares derived: 10-K 12 month − S-1 9 month · filed 2026-08-31 | 3.20M shares 10-K · filed 2026-08-31 |
| 2023-02-28 | 500.00K shares 10-Q · filed 2023-04-10 | |
| 2022-08-31 | 4.60M shares 10-Q · filed 2023-01-09 | |
| 2022-05-31 | 7.90M shares 10-K · filed 2022-08-15 | |
| 2009-05-31 | 3.02M shares 10-K · filed 2012-08-22 |